Monoclonal antibodies target specific molecules or cells in the human body. These antibodies are produced in a laboratory by cloning identical immune cells, allowing for the creation of highly precise and consistent antibodies. Monoclonal antibodies have gained significant attention for their diverse applications since they can be engineered to recognize and bind to a single, predetermined target, such as a disease-causing protein, virus, or cancer cell. This precision makes them invaluable tools for monitoring protein expression in a wide range of diseases, from cancer to autoimmune disorders and infectious diseases.
At NeoBiotechnologies, we create our mouse, rabbit, and rat monoclonals by hybridoma and recombinant techniques. All of our monoclonal antibodies are sequenced multiple times, ensuring lot-to-lot consistency. You can also contact us about bulk orders and licensing for diagnostic and/or therapeutic applications.
